apovincaminic acid has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Felszeghy, K; Keijser, JN; Luiten, PG; Nyakas, C; Szabó, R; Szombathelyi, Z; Tihanyi, K | 1 |
| Dézsi, L; Kárpáti, E; Kis-Varga, I; Komlódi, Z; Nagy, J | 1 |
2 other study(ies) available for apovincaminic acid and Disease Models, Animal
| Article | Year |
|---|---|
Neuroprotective effects of vinpocetine and its major metabolite cis-apovincaminic acid on NMDA-induced neurotoxicity in a rat entorhinal cortex lesion model.
Topics: Animals; Disease Models, Animal; Entorhinal Cortex; Male; Maze Learning; N-Methylaspartate; Neuroprotective Agents; Rats; Rats, Wistar; Vinca Alkaloids | 2009 |
[Neuroprotective effects of vinpocetine in vivo and in vitro. Apovincaminic acid derivatives as potential therapeutic tools in ischemic stroke].
Topics: Animals; Brain Ischemia; Disease Models, Animal; Humans; Ischemic Attack, Transient; Neuroprotective Agents; Rats; Stroke; Structure-Activity Relationship; Vinca Alkaloids | 2002 |